- Research works
- 3 ▲ 80% vs 2013–17
- Citations
- 23 7.0 per fractional work
- Top-10% rate
- 0.0% record average 16.5%
- Open access
- 44% world 28%
Not ranked overall: RDD Pharma (Israel) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Which research topics does RDD Pharma (Israel) publish most on?
By volume in 2022–2025: Parkinson's Disease Mechanisms and Treatments, Medication Adherence and Compliance, Urticaria and Related Conditions and Medicine and Dermatology Studies History.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
- 2 Medication Adherence and Compliance Family Practice 0 works
- 3 Urticaria and Related Conditions Rheumatology 0 works
- 4 Medicine and Dermatology Studies History Dermatology 0 works
- 5 Dermatology and Skin Diseases Dermatology 0 works
- 6 Voice and Speech Disorders Physiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has RDD Pharma (Israel)'s research output changed?
Output in 2018–2022 was 80% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tel Aviv
- Tel Aviv University
- Tel Aviv Sourasky Medical Center
- Assaf Harofeh Medical Center
- General Electric (Israel)
- Israel Atomic Energy Commission
- Clalit Health Services
- Academic College of Tel Aviv-Yafo
- Meta (Israel)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.